GRANULES vs PGHL: Stock Comparison

Granules India Limited vs Procter & Gamble Health Limited

Live data: 22 July 2026, 3:02 PM IST • Source: NSE and company filings

Granules India Limited is the larger company by market capitalisation. Granules India Limited shows faster revenue growth, while Procter & Gamble Health Limited shows a lower P/E, a higher ROE and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Granules India Limited and Procter & Gamble Health Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, GRANULES is more favourable on 3 of 13 scored metrics and PGHL on 10These counts are context-free and are not an overall rating.

Key Differences

Market Cap
GRANULES is the larger company
₹21,049 Cr vs ₹11,172 Cr
P/E Ratio
PGHL has a lower P/E
34.28x vs 36.28x
P/B Ratio
GRANULES has a lower P/B
4.24x vs 21.36x
EPS
PGHL has higher earnings per share
₹196.64 vs ₹24.44
Dividend Yield
PGHL has a higher dividend yield
2.34% vs 0.2%
Revenue Growth (TTM YoY)
GRANULES has faster revenue growth
22.8% vs 19.1%
EPS Growth (TTM YoY)
PGHL has faster EPS growth
54.6% vs 31.3%
Qtr Sales Growth
GRANULES has stronger quarterly sales growth
22.8% vs 19.1%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricGRANULESPGHL
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricGRANULESPGHL
Live Price₹853.25₹6,745.5
Day Change-2.56%-0.5%
Volume14.44 L4,590
52-Week High₹910₹6,975
52-Week Low₹432.6₹4,707
Distance from 52W High-6.24%-3.29%

Valuation

MetricGRANULESPGHL
Market Cap₹21,049 Cr₹11,172 Cr
P/E Ratio36.28x34.28x
P/B Ratio4.24x21.36x
EPS₹24.44₹196.64
Book Value₹205.21₹316.01
Dividend Yield0.2%2.34%

Growth

MetricGRANULESPGHL
Revenue Growth (TTM YoY)22.8%19.1%
EPS Growth (TTM YoY)31.3%54.6%
Qtr Sales Growth22.8%19.1%
Qtr Profit Growth44.6%54.6%

Profitability & Leverage

MetricGRANULESPGHL
ROE13.7%61.6%
ROCE15.5%83.5%
Net Margin11.15%23.22%
Operating Margin22.1%32.4%
Debt to Equity0.3x0.02x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricGRANULESPGHL
Promoter Holding37.67%0%
FII Holding17.5% 2.19 pp6.33% 0.13 pp
DII Holding16.11% 0.9 pp12.44% 1.23 pp
Public Holding28.38% 1.28 pp29.42% 1.11 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Granules India Limited and Procter & Gamble Health Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.